Clinical Trial Update: Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. [Phase 3]

View source ↗

Summary

Phase 3 trial update for chloroprocaine 3% gel eye drops used as a topical anesthetic during phacoemulsification cataract surgery; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Chloroprocaine 3% gel eye drop (Chloroprocaine)

Snippet

Sponsor: Sintetica SA | Conditions: Cataract | Phase 3 | Status: COMPLETED | Results posted: 2022-10-27